Methyl 3-aminocrotonate CAS 14205-39-1: A Key Pharmaceutical Intermediate Supplier for Drug Synthesis

Discover the critical role of Methyl 3-aminocrotonate (CAS 14205-39-1) as a high-purity intermediate for leading pharmaceutical manufacturers. We are a trusted supplier in China, ensuring quality and reliability for your drug development needs.

Get a Quote & Sample

Advantages of Partnering with Us for Methyl 3-aminocrotonate

Consistent Quality & Purity

Our Methyl 3-aminocrotonate consistently meets stringent purity standards (≥98.5%), crucial for pharmaceutical intermediate applications, ensuring reliable reaction outcomes for drug manufacturers.

Robust Supply Chain & Manufacturer Reliability

Benefit from a stable supply of Methyl 3-aminocrotonate from our manufacturing facility. We ensure timely delivery and competitive pricing for businesses looking to buy in bulk from a trusted Chinese supplier.

Expertise in Pharmaceutical Intermediates

Leverage our decade-long experience as a dedicated supplier of pharmaceutical intermediates. We understand the critical needs of R&D scientists and procurement managers seeking high-quality chemical building blocks.

Key Applications of Methyl 3-aminocrotonate

Pharmaceutical Synthesis

Methyl 3-aminocrotonate is a critical intermediate for synthesizing various pharmaceuticals, including calcium channel blockers like Nitrendipine and Amlodipine, vital for treating hypertension.

Organic Synthesis Building Block

Its unique structure makes it a versatile reagent in organic chemistry for developing novel compounds and exploring new chemical reactions, aiding R&D scientists.

Agrochemical Development

This compound finds application in the formulation of agrochemicals, contributing to enhanced crop protection and yield as a key component in effective pesticide development.

Research & Development

Widely used in biochemical research to study enzyme activity and metabolic pathways, it provides insights into biological processes and potential therapeutic targets for pharma companies.